Cargando...
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis
BACKGROUND: The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemokine driving the formation of lymphoid follicles within the inflamed synovium. T...
Guardado en:
| Publicado en: | BMC Rheumatol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604968/ https://ncbi.nlm.nih.gov/pubmed/33292827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00154-3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|